| Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo … CCN Hadi The Lancet 376 (9734), 23-32, 2010 | 2993* | 2010 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 … GBD collaborators lancet, 203-234, 2023 | 1929* | 2023 |
| The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial Crash-2 Collaborators The Lancet 377 (9771), 1096-1101. e2, 2011 | 1444 | 2011 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 546 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 510 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 481 | 2024 |
| Cadmium in human diseases: It’s more than just a mere metal G Fatima, AM Raza, N Hadi, N Nigam, AA Mahdi Indian Journal of Clinical Biochemistry 34 (4), 371-378, 2019 | 233 | 2019 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 224 | 2024 |
| Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis RA Shaker, SH Abboud, HC Assad, N Hadi BMC Pharmacology and Toxicology 19, 1-10, 2018 | 150 | 2018 |
| Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer NG Yousif, FG Al-Amran, N Hadi, J Lee, J Adrienne Cytokine 61 (1), 223-227, 2013 | 118 | 2013 |
| Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response N Hadi, NG Yousif, FG Al-Amran, NK Huntei, BI Mohammad, SJ Ali BMC Cardiovascular Disorders 12, 1-7, 2012 | 111 | 2012 |
| Effects of Tranexamic Acid on Death, Vascular Occlusive Events, and Blood Transfusion in Trauma Patients with Significant Haemorrhage (CRASH-2): A Randomised, Placebo … C trial collaborators The Lancet 376 (9734), 23-32, 2010 | 110 | 2010 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 97 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 GBD collaborators Lancet, 2024 | 97* | 2024 |
| Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats R Sabuhi, Q Ali, M Asghar, NRH Al-Zamily, T Hussain American Journal of Physiology-Renal Physiology 300 (3), F700-F706, 2011 | 77 | 2011 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 76 | 2023 |
| Metformin ameliorates methotrexate-induced hepatotoxicity NR Hadi, FG Al-Amran, A Swadi Journal of Pharmacology and Pharmacotherapeutics 3 (3), 248-253, 2012 | 76 | 2012 |
| Global burden of peripheral artery disease and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 MS Kim, J Hwang, DK Yon, SW Lee, SY Jung, S Park, CO Johnson, ... The Lancet Global Health 11 (10), e1553-e1565, 2023 | 71 | 2023 |
| Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global … RG Bender, SB Sirota, LR Swetschinski, RMV Dominguez, A Novotney, ... The Lancet Infectious Diseases 24 (9), 974-1002, 2024 | 59 | 2024 |
| The Nrf2 activator (DMF) and covid-19: is there a possible role? SM Hassan, MJ Jawad, SW Ahjel, RB Singh, J Singh, SM Awad, NR Hadi Medical archives 74 (2), 134, 2020 | 59 | 2020 |
Bassim I MohammadProfessor of Clinical Pharmacology, University of Al-Qadisiyahqu.edu.iq üzerinde doğrulanmış e-posta adresine sahip